Usl Pharma Company Profile
What is the competitive landscape for USL PHARMA
USL PHARMA has one hundred and three approved drugs.
Summary for Usl Pharma
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 103 |
Drugs and US Patents for Usl Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | FOLIC ACID | folic acid | TABLET;ORAL | 087828-001 | May 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072362-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 087837-001 | Apr 14, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | BACLOFEN | baclofen | TABLET;ORAL | 071261-001 | May 6, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 088719-001 | Jun 27, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087651-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
